Chemical Compound
scopolamine butylbromide
CAS Registry Number
149-64-4
Primary Record
scopolamine butylbromide
- In stock
- 7,852 g
- Purity
- 99.3 %
- CAS
- 149-64-4
Compound Identifiers & Properties
- CAS
- 149-64-4
- PubChem CID
- 6852391
- SMILES
- CCCC[N+]1([C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)[C@H](CO)C4=CC=CC=C4)C.[Br-]
- Canonical SMILES
- CCCC[N+]1(C)[C@@H]2CC(OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@@H]1O[C@@H]12.[Br-]
Names & Synonyms
- scopolamine butylbromide
- Buscopan
- Scobutil
- Scopolan
- Sporamin
- Hyoscine butylbromide
- Buscolysin
- Buscapina
- Buscapine
- Amisepan
- Butylmin
- Monospan
- Scobutyl
- Sparicon
- Tirantil
- Donopon
- Joscine
- Scobron
- Buscol
- Scobro
- Butylhyoscine
- Buscolamin
- Butylscopolamine bromide
- Buscolysine
- Stilbron
- N-Butylscopolammonium bromide
- Scoburen
- Stibron
- 149-64-4
- butylscopolamin
- Buskolamin
- Buscogast
- Hyocimax
- Scopinal
- Antipan
- Spasmin
- HybroCare
- Hyoscine butyl bromide
- Scopolamine bromobutylate
- Hyoscine-N-butyl bromide
- butylscopolaminium
- Hyoscine butobromide
- Spasler-P
- Scopolamine butobromide
- hyoscin butobromide
- N-Butylhyoscine bromide
- Hyoscin-N-butyl bromide
- Hyoscin-N-butylbromid
- Scopolamine butyl bromide
- N-Butylhyoscinium bromide
- BUTYLSCOPOLAMMONIUM BROMIDE
- scopolamine n-butylbromide
- N-Butylscopolamine bromide
- Scopolamine N-butyl bromide
- (-)-N-Butylscopolamine bromide
- N-Butylscopolaminium bromide
- Hyoscine N-Butylbromide
- Opera_ID_556
- RefChem:55683
- Scopolamine impurity 24
- Hyoscine N-butyl bromide
- 9S-Hyoscine Butylbromide
- C21H30BrNO4
- scopolamine-n-butylbromide
- Hyoscine butylbromide CRS
- UNII-0GH9JX37C8
- MLS000069755
- Scopolamine-N-butyl Bromide
- 0GH9JX37C8
- 9-epi-Hyoscine Butylbromide
- Buscopan Injectable Solution
- Butylscopolamine bromide [JAN]
- Hyoscin-N-butylbromid [German]
- Scopolamine N-n-butylbromide
- Hyoscine-N-Butyl Bromide Bp
- MFCD00078561
- SCHEMBL25291
- DTXSID1022718
- (-)-Scopolamine Butylbromide
- C21H30NO4.Br
- MLS002153372
- MLS006013629
- orb104751
- DTXCID102718
- orb3027364
- (-)-Scopolamine-N-butylbromide
- (-)scopolamine N-butyl bromide
- CHEMBL1256901
- SCHEMBL29373202
- C21-H30-N-O4.Br
- CHEBI:32123
- EINECS 205-744-1
- (-)-SCOPOLAMINE N-BUTYL BROMIDE
- HOZOZZFCZRXYEK-GSWUYBTGSA-M
- HOZOZZFCZRXYEK-HNHWXVNLSA-M
- HMS2235K20
- HMS3714I19
- HMS3884J15
- Butylscopolamine bromide [WHO-DD]
- HY-N0340
- MSK11325
- Hyoscine Butylbromide EP Impurity F
- Tox21_112031
- EBC-27103
- Scopolamine butylbromide;Butylhyoscine
- HYOSCINE BUTYLBROMIDE [MART.]
- SCOPOLAMINE BUTYLBROMIDE [JAN]
- SMR000058795
- AKOS016009548
- AKOS037515799
- Tox21_112031_1
- CCG-208412
- CID6852391
- CS-3142
- EBD2197820
- FS10191
- NCGC00163224-01
- NCGC00186628-02
- AC-34139
- AS-78017
- CAS-149-64-4
- N-BUTYLSCOPOLAMMONIUM BROMIDE [MI]
- PD087140
- R028
- SC-19978
- SMR004705104
- SY108844
- AB2000556
- HYOSCINE BUTYLBROMIDE [EP MONOGRAPH]
- ST2407568
- BUTYLSCOPOLAMINE BROMIDE [GREEN BOOK]
- FT-0627164
- FT-0776359
- NS00079272
- F17660
- EN300-7394481
- A884250
- SR-01000759230
- SR-01000759230-3
- (-)-Scopolamine N-butyl bromide, >=98% (TLC), powder
- Hyoscine butylbromide, British Pharmacopoeia (BP) Reference Standard
- [(1S,2S,4R,5R)-9-butyl-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate;bromide
- 150521-07-6
- Hyoscine butylbromide, European Pharmacopoeia (EP) Reference Standard
- Hyoscine butylbromide; (-)-Scopolamine butylbromide; Butylscopolamine bromide
- (1R,2R,4S,5S,7R)-9-butyl-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9-methyl-3-oxa-9-azatricyclo[3.3.1.0,2,4]nonan-9-ium bromide
- (1R,2R,4S,5S,7R)-9-butyl-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9-methyl-3-oxa-9-azatricyclo[3.3.1.0^{2,4}]nonan-9-ium bromide
- (1R,2R,4S,5S,7s)-9-Butyl-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9-methyl-3-oxa-9-azatricyclo[3.3.1.0~2,4~]nonan-9-ium bromide
- (1R,2R,4S,5S,7S)-9-butyl-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane bromide
- (1R,2R,4S,5S,7s,9R)-9-Butyl-7-(((S)-3-hydroxy-2-phenylpropanoyl)oxy)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium bromide
- (1R,2R,4S,5S,7s,9R)-9-Butyl-7-[[(S)-3-hydroxy-2-phenylpropanoyl]oxy]-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium Bromide
- (1R,2R,4S,5S,7s,9S)-9-butyl-7-(((S)-3-hydroxy-2-phenylpropanoyl)oxy)-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium bromide
- (2R,4S,5S,7s)-9-butyl-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.0(2,4)]nonane bromide
- [(1S,2S,4R,5R)-9-butyl-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenyl-propanoate;bromide
- 1-alpha-H,5-alpha-H-Tropanium, 8-butyl-6-beta,7-beta-epoxy-3-alpha-hydroxy-, bromide, (-)-tropate
- 3-Oxa-9-azoniatriciclo [3.3.1.02,4] nonano, 9-butil-7-[(2S)-3-hidroxi-1-oxo-2-fenilpropoxi]-9-metil-, bromuro (1:1 ), (1alfa, 2beta, 4beta, 5alfa, 7beta)-
- 3-OXA-9-AZONIATRICYCLO(3.3.1.0 SUP(2,4))NONANE, 9-BUTYL-7-((2S)-3-HYDROXY-1-OXO-2-PHENYLPROPOXY)-9-METHYL-, BROMIDE (1:1),(1.ALPHA.,2.BETA.,4.BETA.,5.ALPHA.,7.BETA.)-
- 3-Oxa-9-azoniatricyclo(3.3.1.02,4)nonane, 9-butyl-7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9-methyl-, bromide, (7(S)-(1alpha,2beta,4beta,5alpha,7beta))-
- 3-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane, 9-butyl-7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9-methyl-, bromide, [7(S)-(1.alpha.,2.beta.,4.beta.,5.alpha.,7.beta.)]-
- 3-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane, 9-butyl-7-[(2S)-3-hydroxy-1-oxo-2-phenylpropoxy]-9-methyl-, bromide, (1.alpha.,2.beta.,4.beta.,5.alpha.,7.beta.)-
- 9-epi-Hyoscine Butylbromide; 3-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane, 9-butyl-7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9-methyl-, bromide, stereoisomer (9CI); 3-Oxa-9-azatricyclo[3.3.1.02,4]nonane, 3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane deriv.; (1R,2R,4S,5S,7s,9s)-9-butyl-7-[[(2S)-3-hy
- HBB
- Hyoscine Butylbromide; N-Butylscopolammonium bromide; (-)-Scopolamine butylbromide; Amisepan; Buscapine; Buscol; Buscolamin; Buscolysin; Buscolysine; Buscopan; Butylmin; Butylscopolamine bromide; Butylscopolammonium bromide; Donopon; Hyoscine butobromide; Hyoscine butyl bromide; Joscine; Monospan; N-Butylhyoscine bromide; N-Butylhyoscinium bromide; N-Butylscopolamine bromide; N-Butylscopolaminium bromide; Scobro; Scobron; Scobutil; Scobutyl; Scopolamine bromobutylate; Scopolamine butobromide; Scopolamine butyl bromide; Scopolamine-N-butyl bromide; Scopolan; Sparicon; Sporamin; Sporamin (pharmaceutical); Stibron; Tirantil; (1alpha,2beta,4beta,5alpha,7beta)-9-Butyl-7-[(2S)-3-hydroxy-1-oxo-2-phenylpropoxy]-9-methyl-3-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide (1:1); 8-Butyl-6beta,7beta-epoxy-3alpha-hydroxy-1alphaH,5alphaH-tropanium bromide (-)-tropate; [7(S)-(1alpha,2beta,4beta,5alpha,7